Company Filing History:
Years Active: 1989-1997
Title: Paul J Durda: Innovator in Antibody Detection and HIV Research
Introduction
Paul J Durda is a notable inventor based in Needham, MA (US), recognized for his contributions to the field of immunology. He holds a total of 4 patents, showcasing his innovative approach to detecting and quantifying antibody responses.
Latest Patents
Among his latest patents is an assay for detecting and quantifying a mammalian IgA antibody response. This particular disclosure focuses on an assay that utilizes an immobilized EBV-MA gp 350/220, which lacks the transmembrane anchor domain, to detect responses to EBV-MA. Another significant patent involves a chemically synthesized 15 amino acid peptide, designated peptide 1-69, derived from the human immunodeficiency virus-1 (HIV-1) IIIB env-coded protein. This peptide has been shown to elicit antibodies in immunized animals that effectively block HIV proliferation and prevent HIV-induced cell fusion in cell culture.
Career Highlights
Throughout his career, Paul J Durda has worked with prominent companies such as E.I. du Pont de Nemours and Company and Cytocure LLC. His work in these organizations has significantly contributed to advancements in immunological research and therapeutic development.
Collaborations
Paul has collaborated with esteemed colleagues, including David J Green and Marcia J Stone, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Paul J Durda's innovative work in antibody detection and HIV research has made a significant mark in the scientific community. His patents reflect a commitment to advancing medical science and improving health outcomes.